85 related articles for article (PubMed ID: 18509179)
1. Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
Lhommé C; Joly F; Walker JL; Lissoni AA; Nicoletto MO; Manikhas GM; Baekelandt MM; Gordon AN; Fracasso PM; Mietlowski WL; Jones GJ; Dugan MH
J Clin Oncol; 2008 Jun; 26(16):2674-82. PubMed ID: 18509179
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009.
Tiersten AD; Liu PY; Smith HO; Wilczynski SP; Robinson WR; Markman M; Alberts DS
Gynecol Oncol; 2009 Mar; 112(3):444-9. PubMed ID: 19138791
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup.
Bookman MA; Brady MF; McGuire WP; Harper PG; Alberts DS; Friedlander M; Colombo N; Fowler JM; Argenta PA; De Geest K; Mutch DG; Burger RA; Swart AM; Trimble EL; Accario-Winslow C; Roth LM
J Clin Oncol; 2009 Mar; 27(9):1419-25. PubMed ID: 19224846
[TBL] [Abstract][Full Text] [Related]
4. A phase II evaluation of temsirolimus with carboplatin and paclitaxel followed by temsirolimus consolidation in clear cell ovarian cancer: An NRG oncology trial.
Farley JH; Brady WE; O'Malley D; Fujiwara K; Yonemori K; Bonebrake A; Secord AA; Stephan JM; Walker JL; Nam JH; Birrer MJ; Gershenson DM
Gynecol Oncol; 2022 Dec; 167(3):423-428. PubMed ID: 36244829
[TBL] [Abstract][Full Text] [Related]
5. A network meta-analysis of eight chemotherapy regimens for treatment of advanced ovarian cancer.
Jiang XP; Rui XH; Guo CX; Huang YQ; Li Q; Xu Y
Oncotarget; 2017 Mar; 8(12):19125-19136. PubMed ID: 27835912
[TBL] [Abstract][Full Text] [Related]
6. Comparison of paclitaxel liposomes combined with carboplatin versus paclitaxel combined with carboplatin in the treatment of advanced ovarian cancer.
Tan X; Zou S; Chen H; Chen D
J Int Med Res; 2023 Sep; 51(9):3000605231200267. PubMed ID: 37756606
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of standard chemotherapy in older patients with ovarian cancer: a retrospective analysis by age group and treatment regimen.
Brezis MR; Shachar E; Peleg Hasson S; Laskov I; Michaan N; Levy B; Wolf I; Safra T
Front Oncol; 2023; 13():1289379. PubMed ID: 38152363
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous treatment effect of dose-dense paclitaxel plus carboplatin therapy for advanced ovarian cancer.
Taguchi A; Kato K; Furusawa A; Hara K; Sone K; Yamada K; Kajiyama H; Shimada M; Okamoto A
Int J Cancer; 2024 May; ():. PubMed ID: 38712630
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology-based delivery systems to overcome drug resistance in cancer.
Patel H; Li J; Bo L; Mehta R; Ashby CR; Wang S; Cai W; Chen ZS
Med Rev (2021); 2024 Feb; 4(1):5-30. PubMed ID: 38515777
[TBL] [Abstract][Full Text] [Related]
10. Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline.
Boichuk S; Bikinieva F; Valeeva E; Dunaev P; Vasileva M; Kopnin P; Mikheeva E; Ivoilova T; Mustafin I; Galembikova A
Diagnostics (Basel); 2023 Aug; 13(16):. PubMed ID: 37627905
[TBL] [Abstract][Full Text] [Related]
11. A Phase I Trial of the ABCB1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors.
Fracasso PM; Fisher GA; Goodner SA; Beumer JH; Egorin MJ; Fears CL; Wildi JD; Jones GJ; Pearce TE; Sikic BI
Am J Clin Oncol; 2023 Aug; 46(8):353-359. PubMed ID: 37264515
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a Potent, Selective, and Safe Inhibitor, Ac15(Az8)
Chong TC; Wong ILK; Cui J; Law MC; Zhu X; Hu X; Kan JWY; Yan CSW; Chan TH; Chow LMC
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362047
[TBL] [Abstract][Full Text] [Related]
13. The Tetrahydroisoquinoline Scaffold in ABC Transporter Inhibitors that Act as Multidrug Resistance (MDR) Reversers.
Teodori E; Braconi L; Manetti D; Romanelli MN; Dei S
Curr Top Med Chem; 2022; 22(31):2535-2569. PubMed ID: 36284399
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the search of BCRP- and dual P-gp/BCRP-based multidrug resistance modulators.
Dei S; Braconi L; Romanelli MN; Teodori E
Cancer Drug Resist; 2019; 2(3):710-743. PubMed ID: 35582565
[TBL] [Abstract][Full Text] [Related]
15. Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells.
Boichuk S; Dunaev P; Mustafin I; Mani S; Syuzov K; Valeeva E; Bikinieva F; Galembikova A
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327403
[TBL] [Abstract][Full Text] [Related]
16. Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery.
Dragojevic S; Turner L; Raucher D
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216417
[TBL] [Abstract][Full Text] [Related]
17. Dual Targeting of EGFR with PLK1 Exerts Therapeutic Synergism in Taxane-Resistant Lung Adenocarcinoma by Suppressing ABC Transporters.
Shin SB; Kim DH; Kim DE; Aldonza MBD; Kim Y; Yim H
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503223
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of acquired resistance of BRCA1/2-driven tumors to platinum compounds and PARP inhibitors.
Imyanitov E; Sokolenko A
World J Clin Oncol; 2021 Jul; 12(7):544-556. PubMed ID: 34367927
[TBL] [Abstract][Full Text] [Related]
19. Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics.
Lai JI; Tseng YJ; Chen MH; Huang CF; Chang PM
Front Oncol; 2020; 10():561936. PubMed ID: 33312947
[TBL] [Abstract][Full Text] [Related]
20. Role for Drug Transporters in Chemotherapy-Induced Peripheral Neuropathy.
Stage TB; Hu S; Sparreboom A; Kroetz DL
Clin Transl Sci; 2021 Mar; 14(2):460-467. PubMed ID: 33142018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
